ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 331935 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 331935; 2) Community: the network communities that were significantly associated with the response to NSC 331935; 3) Molecule: the relationships between components within communities and NSC 331935; 4) MDR: the compounds that were significantly associated with the NSC 331935.

NSC Compound Enrichment Correlation
NSC 734977 Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate 0.00433056621075582 -0.18847417
NSC 125347 Null 0.00433056621075587 0.29903645
NSC 237020 TA 1067 0.00433056621075587 0.48406385
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.00567322425730619 0.444748
NSC 625731 Null 0.00567322425730619 0.50336198
NSC 627666 1H-Benzo[de]-1,3-benzodioxolo[5,6]quinoline-6a- carbonitrile, 6-benzoyl-1,2-dimethoxy- 0.00567322425730619 -0.34045998
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.00567322425730619 0.51703554
NSC 670784 Null 0.00567322425730619 0.39141975
NSC 734982 Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate 0.00567322425730619 -0.28239132
NSC 155594 Null 0.00626555836518783 0.59093713
Total:67  Current:10    [First] [Prev] [Next] [Last]